The relationship between ring-type dedicated breast PET and immune microenvironment in early breast cancer

Intratumoral heterogeneity on dedicated breast positron emission tomography predicts malignancy grade of breast cancer

(2018) Norio Masumoto et al.   BREAST CANCER RESEARCH AND TREATMENT

Role of 18 F-PET/CT in Predicting Prognosis of Patients With Breast Cancer After Neoadjuvant Chemotherapy

(2018) Etsushi Akimoto et al.   Clinical Breast Cancer

Dedicated breast PET for detecting residual disease after neoadjuvant chemotherapy in operable breast cancer: A prospective cohort study

(2018) Shinsuke Sasada et al.   EJSO

Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy

(2018) Carsten Denkert et al.   LANCET ONCOLOGY

Higher breast cancer conspicuity on dbPET compared to WB-PET/CT

(2017) Kayo Nishimatsu et al.   EUROPEAN JOURNAL OF RADIOLOGY

Potential Utility of FDG PET-CT as a Non-invasive Tool for Monitoring Local Immune Responses

(2017) Seungho Lee et al.   Journal of Gastric Cancer

Correlation of metabolic information on FDG-PET with tissue expression of immune markers in patients with non-small cell lung cancer (NSCLC) who are candidates for upfront surgery

(2016) Egesta Lopci et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Performance evaluation of a high resolution dedicated breast PET scanner

(2016) Trinitat García Hernández et al.   MEDICAL PHYSICS

Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes

(2016) Sasha E. Stanton et al.   JAMA Oncology

Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials

(2015) M. V. Dieci et al.   ANNALS OF ONCOLOGY

Utility of 18F FDG-PET/CT for predicting prognosis of luminal-type breast cancer

(2015) Kenjiro Aogi et al.   BREAST CANCER RESEARCH AND TREATMENT

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

(2014) R. Salgado et al.   ANNALS OF ONCOLOGY

Regulatory T cells in cancer immunotherapy

(2014) Hiroyoshi Nishikawa et al.   CURRENT OPINION IN IMMUNOLOGY

A Molecular Approach to Breast Imaging

(2014) A. M. Fowler   JOURNAL OF NUCLEAR MEDICINE

The Warburg effect then and now: From cancer to inflammatory diseases

(2013) Eva M. Palsson-McDermott et al.   BIOESSAYS

Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer – Usefulness for malignant grade of triple-negative breast cancer

(2013) Masahiro Ohara et al.   BREAST

Role of maximum standardized uptake value in fluorodeoxyglucose positron emission tomography/computed tomography predicts malignancy grade and prognosis of operable breast cancer: a multi-institute study

(2013) Takayuki Kadoya et al.   BREAST CANCER RESEARCH AND TREATMENT

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

(2013) Antonio C. Wolff et al.   JOURNAL OF CLINICAL ONCOLOGY

Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics

(2012) Y Kanda   BONE MARROW TRANSPLANTATION

Clinical Performance of 2 Dedicated PET Scanners for Breast Imaging: Initial Evaluation

(2012) M. Iima et al.   JOURNAL OF NUCLEAR MEDICINE

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

(2010) M. Elizabeth H. Hammond et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical Imaging Characteristics of the Positron Emission Mammography Camera: PEM Flex Solo II

(2009) L. MacDonald et al.   JOURNAL OF NUCLEAR MEDICINE